This company has been acquired
Thorne HealthTech Balance Sheet Health
Financial Health criteria checks 5/6
Thorne HealthTech has a total shareholder equity of $155.3M and total debt of $25.0M, which brings its debt-to-equity ratio to 16.1%. Its total assets and total liabilities are $282.5M and $127.3M respectively. Thorne HealthTech's EBIT is $14.0M making its interest coverage ratio 14.8. It has cash and short-term investments of $17.1M.
Key information
16.1%
Debt to equity ratio
US$24.99m
Debt
| Interest coverage ratio | 14.8x |
| Cash | US$17.09m |
| Equity | US$155.26m |
| Total liabilities | US$127.27m |
| Total assets | US$282.53m |
Recent financial health updates
Recent updates
Results: Thorne HealthTech, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
Aug 12
Thorne HealthTech, Inc. (NASDAQ:THRN) Not Flying Under The Radar
Jun 07Investors Will Want Thorne HealthTech's (NASDAQ:THRN) Growth In ROCE To Persist
Dec 17Thorne HealthTech Grows But Faces Macro Headwinds
Sep 09Thorne HealthTech's blood collection device OneDraw gets clearance in Japan
Aug 23Thorne HealthTech swings to Q2 Non-GAAP loss per share, revenue down Y/Y, FY22 guidance revised
Aug 09Thorne HealthTech: Poised To Outperform Other Nutraceutical Companies
Jun 05Shareholders Can Be Confident That Thorne HealthTech's (NASDAQ:THRN) Earnings Are High Quality
Mar 23Thorne HealthTech: Good Potential At A Low Price
Jan 11Financial Position Analysis
Short Term Liabilities: THRN's short term assets ($135.5M) exceed its short term liabilities ($56.2M).
Long Term Liabilities: THRN's short term assets ($135.5M) exceed its long term liabilities ($71.0M).
Debt to Equity History and Analysis
Debt Level: THRN's net debt to equity ratio (5.1%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if THRN's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: THRN's debt is well covered by operating cash flow (86.1%).
Interest Coverage: THRN's interest payments on its debt are well covered by EBIT (14.8x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/10/18 08:39 |
| End of Day Share Price | 2023/10/13 00:00 |
| Earnings | 2023/06/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Thorne HealthTech, Inc. is covered by 7 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ishan Majumdar | Baptista Research |
| Bryan Spillane | BofA Global Research |
| Susan Anderson | Canaccord Genuity |